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Critical roles for DNA methylation in embryonic
development are well established, but less is known
about its roles during trophoblast development, the
extraembryonic lineage that gives rise to the
placenta. We dissected the role of DNA methylation
in trophoblast development by performing mRNA
and DNA methylation profiling of Dnmt3a/3b mu-
tants. We find that oocyte-derived methylation plays
a major role in regulating trophoblast development
but that imprinting of the key placental regulator
Ascl2 is only partially responsible for these effects.
We have identified several methylation-regulated
genes associated with trophoblast differentiation
that are involved in cell adhesion and migration,
potentially affecting trophoblast invasion. Specif-
ically, trophoblast-specific DNAmethylation is linked
to the silencing of Scml2, a Polycomb Repressive
Complex 1 protein that drives loss of cell adhesion
in methylation-deficient trophoblast. Our results
reveal that maternal DNA methylation controls multi-
ple differentiation-related and physiological pro-
cesses in trophoblast via both imprinting-dependent
and -independent mechanisms.
INTRODUCTION
Fertilization marks the start of a cascade of rapid epigenetic
changes which, coupled to an intricate network of signaling
and transcriptional events, ultimately lead from a totipotent
zygote to amyriad of differentiated tissues that comprise the em-
bryo as well as supporting extraembryonic tissues. DNA methyl-
ation plays essential roles during this time, mainly by mediating
silencing of specific genes and transposable elements. Impor-
tantly, while genome-wide DNAmethylation erasure occurs after
fertilization, key genomic regions are kept methylated, including
imprinting control regions (ICRs) andmurine intracisternal A-par-152 Developmental Cell 36, 152–163, January 25, 2016 ª2016 The Aticle (IAP) retrotransposons (Lane et al., 2003; Smith et al., 2012).
This epigenetic reprogramming phase is followed by de novo
DNA methylation post-implantation, which helps to establish
and cement tissue-specific expression programs, thereby
driving cell differentiation and organogenesis.
In mammals, three DNA methyltransferases (DNMTs) are
responsible for establishing and maintaining DNA methylation
profiles: DNMT1 is mainly involved in themaintenance of methyl-
ation patterns during replication, whereas DNMT3A and
DNMT3B have de novo methylation activity. Mouse knockout
(KO) models have shown that all three enzymes are essential
for correct embryonic development: Dnmt1 and Dnmt3b KOs
are embryonic lethal (Li et al., 1992; Okano et al., 1999), whereas
Dnmt3a KO mice die postnatally (Okano et al., 1999). The com-
bined double KO (DKO) of Dnmt3a and Dnmt3b has a more
severe phenotype than either single KO, with embryos dying at
around embryonic day 10.5 (E10.5) (Okano et al., 1999). Impor-
tantly, conditional deletion of Dnmt3a in the oocyte is sufficient
to halt embryonic development at E10.5 (Kaneda et al., 2004),
showing that maternal methylation is critical for developmental
progression. Maternal KO of Dnmt3l, a catalytically inactive co-
factor that interacts with DNMT3A for the establishment of
DNAmethylation in the oocyte, displays a very similar phenotype
(Bourc’his et al., 2001).
While the role of DNA methylation in the development of the
embryo is well established (Auclair et al., 2014), its importance
in the development of the extraembryonic trophoblast lineage re-
mains less clear. Notably, trophoblast tissues are largely hypo-
methylated when compared with embryonic tissues, in particular
at repeat elements, and embryos derived by nuclear transfer
from ESCs lacking all three active DNMTs can contribute to
extraembryonic tissues when aggregated with wild-type (WT)
embryos (Sakaue et al., 2010). On the other hand, conceptuses
from Dnmt3l-null mothers display morphogenic defects across
all layers of the placenta (Arima et al., 2006). To date, compre-
hensive molecular characterization of the DNA methylation and
gene expression alterations linked to these defects is lacking.
While they have been largely attributed to the loss of imprinted
gene expression, some methylation marks outside of imprinting
are also carried over from the oocyte to the blastocyst stage
(Smallwood et al., 2011), but have not been functionallyuthors
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Figure 1. Oocyte Methylation Is a Major
Regulator of Trophoblast Gene Expression
(A) Females carrying floxed (f) alleles for Dnmt3a
and Dnmt3b as well as a Zp3-driven Cre transgene
were crossed to heterozygous males, yielding four
different genotypes collectively referred to as
mDKO, due to the absence of methylation in the
oocyte; conceptuses from females without the
Zp3-Cre transgene were used as controls.
(B) Maternal deletion of Dnmt3a/3b results in
trophoblast defects at E9.5 (top) characterized by
loss of adhesion of TGCs (arrowheads), with no
apparent difference in phenotype between different
post-zygotic genotypes. In contrast, DKO embryos
are more severely affected than DHet embryos
(bottom). Images are not on the same scale.
(C) H&E staining of paraffin-embedded sections
shows that Dnmt3a mKO trophoblast lacks the
labyrinthine layer that is otherwise seen developing
in WT trophoblast (marked by an asterisk); the TGC
layer is less dense in Dnmt3a KO trophoblast,
possibly due to cell adhesion defects. ch, chorion;
epc, ectoplacental cone.
(D) Hierarchical clustering of mRNA-seq data from
E7.5 EPCs reveals segregation of mDKO and Ctrl
genotypes but no further differentiation of individ-
ual mDKO genotypes.
(E) mRNA-seq expression values for examples of
deregulated genes common to all mDKO geno-
types (top), and genes controlled by post-zygotic
DNAmethylation (bottom). Error bars represent SD.
See also Figure S1.explored. Indeed, of 1,329 CpG islands (CGIs) that are hyperme-
thylated in oocytes relative to sperm, only 23 are associated with
known ICRs (Kobayashi et al., 2012). In this study, we have per-
formed mRNA sequencing (mRNA-seq) and whole-genome
bisulfite sequencing (BS-seq) on trophoblast from Dnmt3a/3b
KO mice. We show that the prevailing phenotype is explained
by the absence of maternal methylation marks. However, failure
to establish correct imprinted gene expression does not explain
all observed transcriptional changes. Our data suggest that
maternal DNA methylation plays critical roles in the control of
cell adhesion in trophoblast giant cells (TGCs) and in the forma-
tion of syncytiotrophoblast (SynT).
RESULTS
Absence of Oocyte DNA Methylation Leads to Cell
Adhesion Defects
To study the role of DNA methylation in trophoblast develop-
ment, we used female mice carrying conditional alleles for both
Dnmt3a and Dnmt3b (Dodge et al., 2005; Kaneda et al., 2004),
as well as a Zp3-Cre transgene; these were crossed to double
heterozygous males, i.e., Dnmt3a+/;Dnmt3b+/ (Figure 1A).
Deletion of Dnmt3a and Dnmt3b driven by Zp3 expression yields
oocytes that lack both enzymes (and virtually all DNA methyl-
ation) (Kaneda et al., 2010; Shirane et al., 2013). Wewill therefore
refer to the group of genotypes resulting from this cross collec-
tively as maternal DKOs (mDKOs), and the individual genotypes
derived from this cross as such: DHet for Dnmt3a/+;Dnmt3b/+,
3aKO for Dnmt3a/;Dnmt3b/+, 3bKO for Dnmt3a/+;
Dnmt3b/, and DKO for Dnmt3a/;Dnmt3b/. To generateDevelopma control cohort, we made a separate cross using females
without the Zp3-Cre transgene (Figure 1A). For simplicity, we
will refer to these genotypes as control (Ctrl) genotypes and
will not distinguish between the various combinations of WT ho-
mozygous and heterozygous alleles generated by this cross.
We first dissected conceptuses at E9.5 for morphological
characterization. As previously described (Okano et al., 1999),
DKO embryos were severely developmentally delayed, with
few defined somites and open neural tube, among other defects,
whereas other genotypes exhibited less pronounced abnormal-
ities (Figure 1B). However, to our surprise trophoblast tissues
showed a very consistent phenotype across all genotypes of
the mDKO cohort, with no obvious additional defects being
observed in DKO trophoblast over DHet trophoblast (Figure 1B).
The most prominent characteristic of these tissues was a reduc-
tion in the adhesion of TGCs that make up the outermost lining of
the implantation site, as these cells were easily dissociated from
the remaining tissue when compared with control trophoblast.
Maternal deletion of Dnmt3a was sufficient to produce the
same phenotype. Histological analysis of Dnmt3a maternal
knockout (mKO) trophoblast at E9.5 revealed defects similar to
those described for Dnmt3l mKO trophoblast (Arima et al.,
2006; Bourc’his et al., 2001). Namely, Dnmt3a mKOs had a
defect in chorio-allantoic fusion that in turn led to a failure in
development of the labyrinthine layer, which can be made out
in WT trophoblast by finger-like invaginations of the allantoic
mesoderm into the chorionic ectoderm layer forming well-
defined fetal blood spaces (Figure 1C). In addition, while the
TGC layer appeared enlarged, this was mostly a result of
reduced tissue density, as there was a notable increase inental Cell 36, 152–163, January 25, 2016 ª2016 The Authors 153
extracellular space in this layer (Figures 1C and S1A). It is
possible that such spacing only becomes apparent as a result
of the histological preparation, but given that WT and mKO tis-
sues were processed in parallel and embedded in the same
paraffin block, this is likely to be an expression of the loss of
cell adhesion seen in dissected tissues. Cellular adhesion plays
key roles in placental development, regulating trophoblast inva-
siveness into the maternal decidua (Harris et al., 2009; Suther-
land et al., 1993). Importantly, dysregulation of adhesion
molecules is commonly observed in placental disorders,
including pre-eclampsia and intrauterine growth restriction
(Harris et al., 2009; Pollheimer and Kno¨fler, 2005). It is therefore
plausible that the developmental arrest of methylation-deficient
conceptuses is due, at least in part, to alterations in the cellular
adhesion profile of trophoblast cells.
mRNA Profiling Reveals Genes Controlled by Oocyte
Methylation
To gain deeper insights into these hypomethylation-induced
changes, we profiled the transcriptome of mDKO and Ctrl tro-
phoblasts. To compare structurally similar tissues and identify
primary, causative aberrations in the gene expression patterns,
we used E7.5 ectoplacental cones (EPCs), at which point
mDKO conceptuses were visually indistinguishable from Ctrl
conceptuses. We performed mRNA-seq of three EPCs from
each genotype group. Interestingly, hierarchical clustering of
the data mirrored our phenotypic observations: Ctrl EPCs clus-
tered together, away from a large group of mDKO EPCs, with
no individual genotype therein being discernible from the others
(Figure 1D). Accordingly, we identified 368 differentially ex-
pressed (DE) genes between Ctrl and DHet EPCs, whereas
comparison of DHet with 3aKO or 3bKO genotypes yielded
only 4 and 6 DE genes, respectively. This strongly suggests
that nearly all transcriptional effects are due to oocyte methyl-
ation deficiency. Interestingly, we did identify 45 DE genes
between DKO and DHet EPCs. As previously described for em-
bryonic tissues (Auclair et al., 2014; Borgel et al., 2010; Hackett
et al., 2012), these include germline-specific genes such asDazl,
Rhox2a, and Tuba3b (Figure 1E). These genes are repressed by
de novo methylation, as post-zygotic deletion of Dnmt3a/3b is
sufficient to cause their upregulation (Figure S1B).
To focus on the group of oocyte methylation-dependent
genes, we selected 137 genes that passed stringent criteria for
differential expression in all mDKO genotypes when compared
with Ctrl EPCs (Table S1). These ‘‘mDKO DE genes’’ were
made up of 39 upregulated and 98 downregulated genes, and
showed very similar expression levels in all mDKO genotypes
(Figure S1C), suggesting that they are solely dependent on
oocyte methylation and not on the presence of DNMTs post-
fertilization. Concordantly, post-zygotic deletion of Dnmt3a/3b
has no effect on the expression of mDKODE genes (Figure S1B).
Among the mDKO DE genes were transcription factors and
markers relevant to trophoblast development, such as Cdx2,
Tpbpa, and Pcdh12 (Figure 1E, RT-qPCR validation in Fig-
ure S1B). Given that Cdx2 is a key trophoblast stem cell (TSC)
transcription factor, we asked whether the TSC niche was
affected inDnmt3amKOmutants by performing immunofluores-
cence for CDX2 on sections of E7.5 conceptuses. We found that
CDX2 depletion only occurred in the EPC and that the extraem-154 Developmental Cell 36, 152–163, January 25, 2016 ª2016 The Abryonic (chorionic) ectoderm, which harbors the TSC niche, re-
mained unaffected (Figure S1D), suggesting that loss of CDX2
is unrelated to deregulation of the stem cell compartment, but
critically affects the diploid core of the EPC. Key markers of
placental development were also affected, including the spon-
giotrophoblast marker Tpbpa and the glycogen cell precursor
marker Pcdh12 (Figures 1E and S1B). Notably, TGC markers
such as Prl3d1/Pl1 were unaffected (Figure S1B), suggesting
that the observed phenotypic alterations are not due tomajor de-
fects in the differentiation of this placental cell type.
Loss of Ascl2 Imprinting Only Partially Explains
Alterations in mDKO Trophoblast
Oocyte methylation controls several ICRs that are essential for
maternal regulation of imprinted genes, which are important for
both embryo and trophoblast development. As previously sug-
gested (Arima et al., 2006), maternal effects on trophoblast
development may therefore be a result of loss of specific im-
printed genes. To test this hypothesis, we first identified known
methylation-dependent imprinted genes within our mDKO DE
gene list. Of 79 imprinted genes (paternal and maternal) in our
mRNA-seq data, 59 were robustly expressed in EPCs from at
least one of the genotypes. However, only five were consistently
altered in all mDKO genotypes: Zrsr1, Cd81, Ascl2, Phlda2, and
Cdkn1c (Figure 2A). Zrsr1 (also known as U2af1-rs1) was upre-
gulated in mDKO EPCs but is unlikely to be involved in the
phenotype of mDKO conceptuses, as mice with paternal disomy
of chromosome 11 (where Zrsr1 lies) are viable (Cattanach and
Kirk, 1985). Cd81, Cdkn1c, Phlda2, and Ascl2, which are all
part of the same imprinting cluster, were all robustly downregu-
lated in mDKO EPCs, as lack of oocyte methylation leads to acti-
vation of the non-coding transcript Kcnq1ot1 on the maternal
allele, which is known to drive silencing of genes in its vicinity
(Peters and Robson, 2008). Cd81 KO mice are viable (Maecker
and Levy, 1997), and both Cdkn1c and Phlda2 KO placentas
are enlarged and show an expansion of the spongiotrophoblast
layer, which is a very different phenotype from that observed in
mDKOs (Frank et al., 2002; Takahashi et al., 2000). However,
trophoblast from maternal KO of Ascl2 (also known as Mash2)
has a severe phenotype mainly characterized by a lack of spon-
giotrophoblast formation, which leads to embryonic lethality at
around E10 (Guillemot et al., 1994). Given the similarity in pheno-
type timing to the mDKO trophoblast, as well as the downregu-
lation of spongiotrophoblast marker Tpbpa observed in both
models, we decided to test whether Ascl2 downregulation was
driving the transcriptional changes seen in mDKO EPCs. For
this purpose, we used anAscl2-lacZ knockin mouse line (Tanaka
et al., 1999) to generatemKO conceptuses of Ascl2. We first per-
formed histological analysis at E9.5, which revealed that Ascl2
mKOs had a reduced or absent labyrinthine layer despite having
completed chorio-allantoic fusion, and had an enlarged TGC
layer (Figure S2A), as previously described (Guillemot et al.,
1994). However, unlike Dnmt3amKO trophoblast, the TGC layer
expansion did not involve a significant increase in extracellular
space (Figure S2B), inferring that TGC cell adhesion is largely
intact in Ascl2 mKO mutants. We then isolated E7.5 EPCs from
Ascl2 WT and mKO conceptuses for RT-qPCR analyses. We
confirmed that Ascl2 repression leads to Tpbpa downregulation,
but also found drastic downregulation of Cdx2 and Pcdh12,uthors
A B
C D
Figure 2. Ascl2 Depletion Does Not Drive the
Bulk of Gene Expression Alterations in
mDKO EPCs
(A) mRNA-seq data reveal deregulated maternally
controlled imprinted genes in DHet EPCs (red),
whereas a paternally controlled imprinted gene is
unchanged (Igf2, blue).
(B) RT-qPCR data from Ascl2 WT and mKO E7.5
EPCs shows that some key genes deregulated in
mDKO EPCs are driven by Ascl2 downregulation
(*p < 0.05, **p < 0.01, ***p < 0.001; t test). Error bars
represent SD.
(C) Differential expression analysis from mRNA-seq
of Ascl2 mKO EPCs reveals that only a minority of
Dnmt3 mDKO DE genes are explained by Ascl2
repression.
(D) Log2 fold change in expression betweenWT and
Ascl2 or Dnmt3 mutant EPCs for each grouping of
genes defined in (C). Ascl2-dependent genes
display similar expression changes inDnmt3mDKO
EPCs, whereas Dnmt3 unique DE genes are un-
changed in Ascl2 mKO EPCs.
See also Figure S2.similar to that seen in Dnmt3 mDKO EPCs (Figure 2B). We then
extended this analysis by performing mRNA-seq on control
and Ascl2 mKO EPCs. We found that, while 43 genes were
commonly deregulated between Ascl2 mKO and Dnmt3 mDKO
EPCs, there were 94 DE genes that were unique to the Dnmt3
mDKOs (Figure 2C). Surprisingly, we also found 216 genes
seemingly only deregulated in Ascl2 mKOs. However, when we
analyzed the expression of these genes in Dnmt3 mDKO EPCs,
we found that they displayed expression changes very similar
to those seen in Ascl2 mKOs (Figure 2D), but had not passed
our stringent criteria for differential expression calling. Impor-
tantly, genes deregulated only in the Dnmt3 mDKO EPCs did
not display substantial changes in expression in Ascl2 mKOs
(Figure 2D), demonstrating that these are indeed Ascl2-indepen-
dent effects. Our data suggest that the majority of transcriptional
alterations inmDKO trophoblast are independent of imprinting of
a key regulator of placental development. While we cannot
completely rule out that the combined loss of imprinting at other
loci may drive the gene expression changes seen in mDKOs, it is
likely that maternally derived methylation marks outside of ICRs
play a major role in trophoblast gene regulation.
mDKO-Affected Genes Are Involved in Trophoblast
Development and Adhesion
Wedecided to focus on the group of 94 genes that were affected
in Dnmt3 mDKO but not Ascl2 mKO EPCs. Gene ontology (GO)
analysis revealed that thisDnmt3-specific gene list was enriched
for genes involved in signal transduction (e.g., Ephb2, Stk10,
Pik3ap1,Ptpn3) and the regulation of guanosine triphosphatases
(GTPases) (e.g., Asap1, Rgs3, Arhgef4, Rasa4) (Table S2),
whereas no such enrichment was seen in Ascl2-specific genes
(Table S3). GTPases control many key cellular processes,
including focal adhesion and migration/invasion (Menke and
Giehl, 2012), which is consistent with the cellular adhesion defect
observed in mDKO trophoblast. Notably, numerous other genes
involved in cell adhesion were found to be deregulated in mDKO,
such as Itga7, Flnc,Dbnl, and Plxna1. Although the GO term ‘‘cellDevelopmadhesion’’ did not reach significance in our analysis, we noted
that many deregulated genes with known roles in cell adhesion
and migration lack this annotation (e.g., Asap1, Rasa4, Srgap3,
Spry1). Acquisition of an invasive phenotype is a key component
of the differentiation process of TGCs (Hemberger et al., 2003;
Hunkapiller et al., 2011). In line with this, Ephb2, a receptor tyro-
sine kinase that activates Rho family GTPases and is involved in
the formation of secondary TGCs (El-Hashash and Kimber,
2006), was downregulated in mDKO EPCs. Other deregulated
genes involved in trophoblast differentiation includedGata3 (Ral-
ston et al., 2010), Gjb5 (Kibschull et al., 2014), Dlx3 (Morasso
et al., 1999), and Alkbh1/2700073G19Rik (Pan et al., 2008).
This prompted us to ask whether mDKO-affected genes were
generally associated with trophoblast differentiation. Genes an-
notated with GO terms associated with trophoblast or placental
development were not significantly enriched (although we again
found this annotation to be incomplete). However, five out of six
tested genes showing upregulation in mDKO EPCs were found
to increase in expression during differentiation in vivo (Figure 3A),
and similar results were obtained during in vitro differentiation of
TSCs (Figure S3). To expand on these observations using an
annotation-independent approach, we examined the behavior
of mDKO-affected genes in expression data from E9.5 WT
TGCs (Sher et al., 2013) and found that most of these genes
are indeed differentially expressed relative toWTE7.5 EPCs (Fig-
ure 3B). Moreover, their expression inmDKOE7.5 EPCswaswell
correlated with the expression profile of E9.5 TGCs (Figure 3B),
indicative of precocious TGC differentiation in mDKO tropho-
blast. Although some TGC markers (such as Prl3d1) are un-
changed inmDKOEPCs (Figure S1B), it is likely that deregulation
of these TGC-associated genes affects the function of this cell
population.
Trophoblast invasion and placental development critically
depend on epithelial-to-mesenchymal transition (EMT) (Kokki-
nos et al., 2010; Parast et al., 2001; Sutherland, 2003). Notably,
apart from signal transduction and GTPase regulators, other
mDKO-deregulated genes with known roles in EMT includedental Cell 36, 152–163, January 25, 2016 ª2016 The Authors 155
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Figure 3. mDKO DE Genes Are Associated with Trophoblast Differentiation
(A) Several Dnmt3-specific genes affected in mDKO EPCs become upregulated during trophoblast development, as revealed by RT-qPCR of E7.5 and E9.5 WT
trophoblast.
(B) Expression of mDKO DE genes in E9.5 TGCs relative to E7.5 EPCs. mRNA-seq data from E9.5 TGCs (Sher et al., 2013) were plotted against our mRNA-seq
data for Ctrl (left) or mDKO (right) E7.5 EPCs. Genes upregulated in mDKO EPCs (green) have increased expression in TGCs relative to WT E7.5 EPCs. Similarly,
mDKO downregulated genes (red) tend to have lower expression in TGCs. When plotted against mDKO EPC data, the expression of mDKO DE genes is much
more comparable with that seen in TGCs.
(C) RT-qPCR of EMT-associated genes in E9.5 trophoblast reveals that mDKO trophoblasts do not exhibit a classic EMT phenotype, although Cdh1 is
downregulated.
Error bars represent SD. *p < 0.05, **p < 0.01, ***p < 0.001; t test comparing E9.5 with E7.5 (A), or ANOVA with post hoc tests comparing control (Ctrl) and mDKO
genotypes (C). See also Figure S3.Mmp15 (Tao et al., 2011) and Grhl2 (Cieply et al., 2012). How-
ever, genes widely involved in EMT (e.g., Cdh1, Snai1, Zeb1)
were not significantly altered in our E7.5 mRNA-seq data. To
test whether an overt EMT phenotype expressed itself at a later
developmental stage, we measured the expression of key EMT-
associated genes in E9.5 Ctrl andmDKO trophoblast (Figure 3C).
While we did observe a prominent decrease in the classic epithe-
lial marker Cdh1 (E-cadherin), this was unexpectedly accompa-
nied by a comparable reduction in the mesenchymal marker
Cdh2 (N-cadherin). Similarly, while EMT is commonly driven
by the expression of Snai1/2 (Snail and Slug), Twist1/2, and
Zeb1/2, we found either no change or a robust decrease in the
expression of these genes (Figure 3C). These results indicate
that the cell adhesion changes observed in mDKO trophoblast
do not display the characteristics of a classic EMT and may be
driven by independent or non-canonical pathways.
Contrary to what has been previously suggested (Sakaue
et al., 2010), these data show that oocyte methylation, directly
or indirectly, regulates genes that are important for trophoblast
differentiation and function. Notably, genes involved in signal
transduction pathways that control adhesion and migration are
particularly affected.
Methylation-Deficient TSCs Display Cell Adhesion
Defects
To further investigate the link between DNA methylation and
cellular adhesion, we cultured TSCs null for all three active
DNA methyltransferases (Dnmt1, Dnmt3a, and Dnmt3b) and156 Developmental Cell 36, 152–163, January 25, 2016 ª2016 The Acompared them with WT TSCs; both being derived from nuclear
transfer embryos (Sakaue et al., 2010). We observed that WT
cells grew as flat epithelial colonies with sharp boundaries as
is characteristic of TSCs, whereas triple-knockout (TKO) TSCs
did not form distinct colonies but instead exhibited a much
more disorganized morphology and a notable loss of discrete
colony margins (Figure 4A). In WT TSCs, E-cadherin delineated
cell-cell junctions within colonies, whereas in TKO TSCs such
junctions were less frequent and instead fibroblast-like cyto-
plasmic protrusions were visible, suggestive of an increased
migratory capacity. Furthermore, using an assay to measure
cell adhesion to tissue culture wells, we found that TKO TSCs
were less adherent than WT cells on uncoated wells (Figure 4B).
Interestingly, the difference could be rescued by laminin, sug-
gesting that the adhesion defect can be overcome by changing
the ECM/substrate composition. These differences were not due
to cell differentiation, as TKO TSCs retained expression of key
TSC markers (Figures S4 and 6G). In addition, TSCs derived
from Ascl2 mKO trophoblast do not display any morphological
abnormalities compared with their WT counterparts (A.B.B.
and L.L., unpublished data), ruling out a role for the loss of
Ascl2 imprinting in the TKO TSC phenotype.
To test whether loss of cell adhesion in TKO TSCs was driven
by deregulation of the same genes identified in mDKO tropho-
blast, we plotted the expression changes of mDKO DE genes
in TKO TSCs using published microarray data (Figure 4C) (Sa-
kaue et al., 2010). We found that mDKO upregulated genes are
also derepressed in TKO TSCs, supporting a role for DNAuthors
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Figure 4. Loss of DNA Methylation Drives a
Cell Adhesion Defect in TSCs
(A) E-cadherin staining of WT and TKO TSCs
highlights that TKO TSCs do not display the typical
epithelial colonymorphology of ESCs, appearing to
exhibit reduced cell adhesion and increased
migration.
(B) TKO TSCs also have reduced adhesion capacity
to cell culture wells, but only in the absence of the
extracellular matrix component laminin.
(C) Gene expression differences (log2 fold change)
between TKO andWT ESCs or TSCs for all mDKO-
deregulated genes. Dnmt3 upregulated genes are
derepressed in TKO TSCs (but not ESCs), consis-
tent with a direct role of DNA methylation in their
regulation, whereas downregulated genes are un-
changed.
(D) RT-qPCR on TKO TSCs shows expression
changes consistent with those seen in mDKO
trophoblast (Scml2 and Spry1) and raised expres-
sion of mesenchymal markers (Cdh2 and Snai2).
Bar plot error bars represent SD. **p < 0.01, ***p <
0.001; t test comparingWTwithTKOTSCs (BandD),
or one-sample t test (C). See also Figure S4.methylation in their silencing. In contrast, mDKO downregulated
genes were unaffected, suggesting that they are likely indirect
effects that occur in the context of trophoblast differentiation.
Interestingly, in contrast to TKO TSCs, TKO ESCs showed no
changes in the expression of mDKO upregulated genes (Fig-
ure 4C), indicating that TSC-specific transcription factors are
required to activate these genes. In line with this hypothesis,
we found that mDKO upregulated genes (but not downregulated
genes) were enriched for sites bound by both ELF5 and TFAP2C
(p = 1.3 3 1010) (Latos et al., 2015).
Using RT-qPCR onWT and TKO TSCs we confirmed the dere-
pression of Scml2, which was the top mDKO upregulated gene
(Figure 4D). Equally concordant with the in vivo data was the
downregulation of Spry1, which is a major EGFR signaling regu-
lator that controls cell adhesion and migration (Mekkawy et al.,
2014). We also detected an increase in the expression of the
mesenchymal markers Cdh2 and Snai2 (Figure 4D), although
this was not accompanied by significant changes in Cdh1 or
Snai1 (Figure S4), suggesting that, similarly to themDKO tropho-
blast, canonical EMT is not involved in the loss of cell adhesion in
TKO TSCs.
These results further support a critical role for DNA methyl-
ation in the regulation of cell adhesion in trophoblast.
ASubset ofmDKOUpregulated Genes Are Controlled by
DNA Methylation
We next sought to identify which genes were likely to be regu-
lated through the direct action of DNA methylation. To link
gene expression changes with alterations in DNA methylation
patterns, we performed whole-genome BS-seq of Ctrl, DHet,
and DKO E7.5 EPCs. As expected, DKO EPCs showed deepDevelopmental Cell 36, 152–163and widespread hypomethylation across
several genomic features, including gene
promoters, gene bodies, and LINE1 retro-
transposons (Figure 5A). IAP retrotranspo-sons were largely resistant to demethylation, consistent with
DNMT1 being sufficient to maintain DNA methylation at these
sites (Arand et al., 2012).
DHet EPCs displayed a slight reduction in DNA methylation
across most genomic features (Figure 5A). To test whether
this was solely due to a loss of oocyte methylation, we
compared our data with published data on CGI methylation in
oocytes and blastocysts (Kobayashi et al., 2012). Most CGIs
that are partially resistant to demethylation during pre-implan-
tation development are methylated in oocytes (Figure S5)
(Smallwood et al., 2011). We therefore asked whether these
reprogramming-resistant CGIs were more likely to be hypome-
thylated in DHet EPCs when compared with de novo methyl-
ated CGIs. Our analysis shows that, overall, both groups of
CGIs undergo a similar loss of methylation in DHet EPCs
(Figures 5B and S5). In contrast, maternally methylated ICRs
displayed a markedly more pronounced loss of methylation
(Figure 5B). Therefore, it appears that the global hypomethyla-
tion seen in EPCs is a result of haploinsufficiency of Dnmt3a
and/or Dnmt3b during the de novo methylation phase. How-
ever, the lack of correlation between the post-zygotic genotype
and expression of mDKO DE genes (Figure S1C) argues against
a major role of haploinsufficiency in driving the mDKO
phenotype.
To exclude these small genome-wide differences in DNA
methylation, we performed an unbiased search for differentially
methylated regions (DMRs) between DHet and Ctrl EPCs that
displayed at least a 20% methylation difference. We identified
6,685 DMRs, nearly all of which (96.6%) involved a loss of
methylation in DHet EPCs and were seemingly not enriched
at CGIs, promoters, gene bodies, or placental enhancers, January 25, 2016 ª2016 The Authors 157
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Figure 5. DNA Methylation Differences Are Associated with DE Genes
(A) DNA methylation profiling by BS-seq shows that DHet EPCs have a slight genome-wide reduction of DNA methylation.
(B) CGIs methylated (>25%) in Ctrl EPCs were separated into reprogramming-resistant (>25% methylation in blastocyst; Kobayashi et al., 2012) or de novo
methylated (<15% methylation in blastocyst). Methylation levels in Ctrl and DHet EPCs (left) and the relative methylation change between the two (right) shows
that both subsets are hypomethylated to a similar extent in DHet EPCs; maternally methylated ICRs (blue) undergo more extensive methylation loss.
(C) BS-seq profiles of methylation levels at example loci containing DHet DMRs (highlighted in green) that are associated with genes displaying altered gene
expression.
See also Figure S5.predicted from the mouse ENCODE project. Around 67% of
DMRs had more than 80% methylation in WT oocytes (Kobaya-
shi et al., 2012), whereas only 46% of randomly generated
regions passed the threshold, suggesting an important contri-
bution of oocyte methylation to these DMRs. We identified 59
DMRs lying within 20 kb of mDKO DE genes (excluding
Ascl2-dependent effects), covering 35 out of 94 DE genes
(see examples in Figure 5C). Surprisingly, these DMRs were
associated with both upregulated (n = 14) and downregulated
(n = 21) genes. To further probe which gene expression alter-
ations were likely to be directly regulated by DNA methylation,
we asked which genes were also affected in TKO TSCs.
Notably, 6 out of 14 DMR-associated genes that were upregu-
lated in mDKO EPCs were also more than 2-fold upregulated in
TKO TSCs. Five of these genes (Dst, Plekha6, Stk10, Ptpre, and
Plcb4) encoded an actin-binding protein, a phospholipid-bind-
ing adaptor, a protein kinase, a protein tyrosine phosphatase,
and a phospholipase that are implicated in cell adhesion and
signal transduction.
These data reveal that a number of oocyte-dependent DMRs
are linked to genes deregulated in mDKO EPCs, a subset of158 Developmental Cell 36, 152–163, January 25, 2016 ª2016 The Awhich appear to be directly controlled by DNA methylation in a
trophoblast-specific manner.
Scml2 Is Hypomethylated in mDKO EPCs and Affects
Trophoblast Differentiation and Adhesion
One of the DMRs we identified overlapped Scml2 (Figure 5C),
which was the most upregulated gene in mDKO EPCs, and
was also highly upregulated in TKO TSCs (Figure 4D). SCML2
is a non-canonical member of the Polycomb Repressive Com-
plex 1 (PRC1), which plays important epigenetic roles in the
establishment of the male germline (Hasegawa et al., 2015;
Luo et al., 2015). We therefore investigated whether Scml2
silencing was important for trophoblast development and adhe-
sion. Firstly, we confirmed that Scml2 upregulation in mDKO
EPCs was driven by the maternal deletion of Dnmt3a (Fig-
ure 6A). We then validated the DMR associated with Scml2 us-
ing Sequenom MassARRAY, which showed a specific loss of
methylation in DHet and DKO EPCs near an intragenic tran-
scription start site (TSS) (Figure 6B). This alternative promoter
overlaps a CGI (highlighted in Figure 5C) that is 95% methyl-
ated in WT oocytes (losing all methylation in Dnmt3l-nulluthors
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Figure 6. Scml2 Is Controlled by DNA Methylation and Affects SynT Formation and Cell Adhesion
(A) RT-qPCR of Dnmt3a mKO EPCs confirms that Scml2 is controlled by oocyte methylation.
(B) Methylation analysis by Sequenom MassARRAY in E7.5 male EPCs, confirming the DMR at an intragenic TSS of Scml2. Each data point may include more
than one CpG from the amplicon, as indicated on the x axis.
(C) RT-qPCR analysis of TSCs grown in FGF+ (TSC conditions) or FGF (differentiation conditions) medium for 6 days, with or without Scml2 overexpression.
(D) Expression of Syna is reduced in Dnmt3a mKO EPCs, whereas markers of SynT-II Synb and Cebpa are unaffected.
(E) E-cadherin staining of two independent Scml2 knockout clones from TKO TSCs shows a rescue of the morphological alterations seen in TKO TSCs.
(F) Scml2 KO on TKO TSCs also rescues the defect in cell adhesion to cell culture wells in the absence of laminin.
(G) RT-qPCR analysis of TKO Scml2 KO clones shows maintained expression of the TSC marker Cdx2; the expression of genes involved in cell adhesion is not
rescued upon Scml2 deletion.
Error bars represent SD. *p < 0.05, **p < 0.01, ***p < 0.001; t test comparing WT and Dnmt3a mKO EPCs (A and D) or Scml2-expressing TSCs versus vector
control (C), or ANOVA with post hoc tests comparing Ctrl with DHet/DKO (B) or TKO TSC lines with WT TSCs. See also Figure S6.oocytes) and 34% methylated in blastocysts (Kobayashi et al.,
2012), supporting the notion that Scml2 methylation levels are
carried over from the oocyte through the pre-implantation
phase. Interestingly, maintenance of methylation and silencing
of Scml2 are specific to the trophoblast compartment, as
methylation in the epiblast is lost and Scml2 is expressed (Fig-
ure S6A). This pattern is also clearly observed when comparing
ES and TS cells (Figure S6A). Scml2 lies on the X chromosome,Developmbut while Scml2 is unmethylated in X-containing sperm (Ko-
bayashi et al., 2012), no placental Scml2 expression is ex-
pected from the paternal allele in females due to imprinted X
inactivation in mouse trophoblast. Accordingly, we found no
difference in Scml2 expression levels between male and female
EPCs within Ctrl or mDKO genotypes. Furthermore, X inactiva-
tion appeared unaffected in female DHet EPCs, as Xist expres-
sion was unchanged. Importantly, the X-linked nature of Scml2ental Cell 36, 152–163, January 25, 2016 ª2016 The Authors 159
makes its epigenetic regulation distinguishable from a genomic
imprinting mechanism.
To test the effect of Scml2 expression on trophoblast
morphology and development, we overexpressed Scml2 in
TSCs (Scml2 expression levels in Figure S6C). When cells were
grown under stem cell conditions (fibroblast growth factor
[FGF]+), we found no significant differences in morphology or
cell adhesion (Figure S6B) upon overexpression of Scml2. There
were also no detectable differences in the expression of key TSC
markers (Figure S6C). However, after induction of TSC differen-
tiation by removal of FGF from the medium, Scml2 impaired the
expression of Syncytin A (Syna), a marker of SynT-I (which inter-
faces the maternal blood), while no effect was seen on other dif-
ferentiation markers, including markers of TGCs and SynT-II
(Figure 6C and data not shown). This suggests that Scml2
silencing is important for SynT-I formation in WT trophoblast.
Accordingly, Dnmt3a mKO trophoblast also displayed reduced
Syna expression at E7.5 but no alterations in SynT-II markers
Synb and Cebpa (Figure 6D). While we found that the latter
markers were markedly reduced at E9.5, this reflects the
absence of the developing labyrinthine layer observed in these
mutants. However, the early change seen in Syna expression
at E7.5 occurs prior to the morphological establishment of
SynT and the labyrinth, suggesting that it is a direct effect of
methylation deficiency. In contrast, whileAscl2mKO trophoblast
also displays a reduction in Syna expression at E9.5 due to a
reduction of the labyrinthine layer (Oh-McGinnis et al., 2011),
no difference is detected at E7.5 (Figure S6D).
As SCML2was not sufficient to drive cell adhesion defects, we
asked whether it was necessary for the phenotype, in combina-
tion with other methylation-dependent expression changes. We
therefore used CRISPR/Cas9 gene editing to delete Scml2 in
TKO TSCs (Figure S6E). Strikingly, both Scml2 KO clones that
were established displayed a distinct morphology from the
parental TKO TSCs, closely resembling the WT colony arrange-
ment (Figure 6E). TKO Scml2 KO clones also showed a restored
ability to attach to cell culture wells comparable with WT levels
(Figure 6F). This was not due to changes in cell differentiation
state, as cells maintained expression of TSC markers and did
not show upregulation of differentiation markers (Figure 6G
and data not shown). Loss of SCML2 did not rescue the rise in
Cdh2 expression seen in TKO TSCs (Figure 6G). We then asked
whether loss of SCML2was rescuing the cell adhesion defect via
modulation of some of the other DE genes identified in mDKO
trophoblast. None of the nine genes tested (e.g., Spry1 and
Itga7) showed significant differences between TKO TSCs and
the TKO Scml2 KO clones (Figure 6G), suggesting that Scml2
acts through an independent pathway. Impairment of cell adhe-
sion in TKO TSCsmay therefore require both SCML2-dependent
pathways together with other methylation-dependent alterations
seen in vivo. This is in line with SCML2 overexpression being
insufficient to drive cell adhesion changes (Figure S6B).
DISCUSSION
Our phenotypic, molecular, and functional analyses show that,
contrary to previous reports (Sakaue et al., 2010), DNA methyl-
ation is essential for early trophoblast development. In particular,
our work demonstrates that maternal methylation (and its main-160 Developmental Cell 36, 152–163, January 25, 2016 ª2016 The Atenance during pre-implantation development) plays a major
regulatory role in trophoblast differentiation and function. This
encompasses the need for controlling imprinted genes (Ascl2),
but also non-imprinted genes, as demonstrated by the specific
example of Scml2, which we have shown to affect Syna expres-
sion and cell adhesion. Moreover, methylation at the Scml2 pro-
moter is specifically maintained in the EPC and lost in the
epiblast (Figure S6A), highlighting the need for targeting DNA
methylation to the trophoblast compartment at specific loci.
Loss of imprinting at methylation-dependent loci other than
Ascl2 is also known to have an impact on placental function at
later developmental stages (Tunster et al., 2013), further empha-
sizing the importance of maternal methylation.
Although non-imprinted oocyte methylation marks have been
generally associated with brain- and testis-linked genes (Rut-
ledge et al., 2014), we have identified critical trophoblast genes
that are regulated through maternal DNA methylation (directly
or indirectly). Deregulated genes were enriched for signal trans-
duction and regulators of Ras and Rho family GTPases, which
are implicated in cell adhesion and migration. Along with the
decreased Cdh1 expression seen in E9.5 DHet trophoblast (Fig-
ure 3C), these alterations are in line with the cellular adhesion
phenotype seen in mDKO TGCs. Interestingly, links between
DNA methylation and EMT have been described in human
trophoblast cell lines (Chen et al., 2013a; 2013b). Epigenetic
regulation of mouse trophoblast migration and invasion has
also been described through the action of the histone lysine de-
methylase LSD1 (Zhu et al., 2014). Similar to some of our obser-
vations, LSD1 depletion in TSCs leads to early differentiation
onset, which disrupts their epithelial morphology and increases
cell migration and invasion. However, we only found one gene
(Reep6) in common between mDKO DE genes and LSD1-regu-
lated genes, suggesting that separate epigenetic mechanisms
act on different pathways to regulate the crucial processes of
cell adhesion and control of invasive behavior in trophoblast.
We uncovered Scml2 as a putative methylation-controlled
gene that is kept silent in the trophoblast lineage to allow for
appropriate control of cell adhesion and Syna expression. The
relatively low methylation levels of Scml2 in Ctrl EPCs suggest
that other mechanisms aid in its silencing. We also cannot
completely exclude the possibility that Scml2 expression is indi-
rectly controlled by DNA methylation. In the male germline,
SCML2 regulates PRC1-dependent ubiquitination of histone
H2A either positively or negatively, in a context- and target-
dependent manner (Hasegawa et al., 2015). SCML2 may there-
fore regulate the expression of genes involved in the control of
cell adhesion and migration, as well as of Syna. Notably, based
on our Scml2 overexpression experiment, hypomethylation of
Scml2 is not sufficient to drive the adhesion defects, implicating
maternal DNA methylation more widely in the regulation of cell
adhesion and migration, as discussed above. Interestingly, hu-
man SCML2 interacts with SFMBT2 (Zhang et al., 2013), another
PcG protein whose ortholog in mouse is essential for placental
development (Miri et al., 2013). Sfmbt2 is a paternally expressed
imprinted gene, but silencing of the maternal allele is inde-
pendent of DNA methylation (Okae et al., 2012). However, the
epigenetic control of SCML2 during human pre-implantation
development appears to differ from that of the mouse, as
the syntenic region to the DMR that we identified (also at authors
TSS and CGI in the human) is largely unmethylated in human oo-
cytes and morulae (Figure S6F) (Guo et al., 2014). Differences in
placental morphology and organization may ultimately be driven
by such gene-regulatory changes throughout evolution. Notably,
the X chromosome is particularly enriched in trophoblast-associ-
ated genes and has been argued to be an important driver of
placental evolution and speciation (Hemberger, 2002). Along
with this argument, it is interesting to note that Scml2 is X-linked
exclusively in eutherians.
Our study highlights a critical and widespread role of oocyte
methylation in the development of the placenta. Although we
cannot completely rule out that other imprinted genes are
involved in the early mDKO phenotype we describe, their known
placental roles (Tunster et al., 2013) and our data strongly sug-
gest that additional, non-imprinted methylation marks also con-
trol trophoblast development. Interestingly, when we measured
human oocyte and morula methylation at regions syntenic to
our mouse DMRs, we found that CpGs within these regions
are generally hypermethylated when compared with the rest of
the genome (Figure S6G). It is tempting to speculate that conser-
vation of methylation at these sites is relevant for human
placental development, and that oocyte methylation evolved to
play a major role in the trophoblast lineage.
EXPERIMENTAL PROCEDURES
Mouse Lines and Tissue Preparation
All experimental procedures were performed under licenses by the Home
Office (UK) in accordance with the Animals (Scientific Procedures) Act 1986.
Mice carrying conditional deletions of both Dnmt3a and Dnmt3b (Okano
et al., 1999), or of Dnmt3a alone, and with or without a Zp3-Cre transgene
were crossed by natural mating. Female mice heterozygous for an Ascl2-
lacZ allele (Tanaka et al., 1999) were crossed toWTmales. For immunofluores-
cence, E7.5 implantation sites were fixed with 4% paraformaldehyde (PFA)
and processed as for routine paraffin histology. For RNA and DNA isolation,
trophoblast and epiblast tissues were dissected from E7.5 or E9.5 concep-
tuses and snap-frozen.
Tissue Culture and Scml2 Overexpression/Knockout
Blastocyst-derived TS-EGFP cells (a kind gift from Dr. Janet Rossant) or WT/
TKO TSCs derived from nuclear transfer embryos (Sakaue et al., 2010) were
cultured under routine conditions (20% fetal bovine serum, 1mMNa-pyruvate,
penicillin/streptomycin, 50 mM 2-mercaproethanol, 25 ng/ml basic FGF
(Sigma) and 1 mg/ml heparin in RPMI 1640, with 70%of themedium pre-condi-
tioned on embryonic feeder cells). For Scml2 overexpression, the open
reading frame of the isoform that starts at the intragenic CGI-associated
TSS was cloned via Gateway cloning (Life Technologies) into a PiggyBac vec-
tor and sequence-verified. This construct or the empty vector were co-trans-
fected with a PiggyBac transposase plasmid using Lipofectamine 2000 (Life
Technologies) or Fugene 6 (Promega), according to the manufacturer’s in-
structions. Integrants were selectedwith 5 mg/ml blasticidin S, after which cells
were switched to TS cell differentiation medium (unconditioned medium
without basic FGF or heparin) for the indicated times. For CRISPR/Cas9-medi-
ated deletion of Scml2, TKO TSCs were co-transfected with pCAG-cGFP-
blasticidin and pCas9.2A.GFP/Puro (Ran et al., 2013) harboring guide RNAs
flanking exon 3 (Figure S6D): GTTCATCCCTAGGCAATTAT, CAGGGA
TGTTTGCAACGTGC. After 48 hr of blasticidin selection, single cells were
sorted by flow cytometry and left to grow for 10–14 days before genotyping
(see Supplemental Experimental Procedures, Primers).
Histology and Immunofluorescence
Paraffin sections were deparaffinized with Histo-Clear and dehydrated
through an ethanol series, followed either by standard H&E staining or antigen
retrieval by boiling slides for 30min (in 1mMEDTA, 0.05%Tween 20, pH 8) andDevelopmcooling at room temperature for 20min. After blocking with 1%BSA overnight,
sections were incubated with a rabbit monoclonal anti-CDX2 antibody
(EPR2764Y, Novus Biologicals, 1:250 dilution) for 2 hr. Secondary detection
was done with an AlexaFluor 488 anti-rabbit antibody (Life Technologies,
1:500 dilution). TSCs were fixed with 4% PFA, permeabilized with Triton
X-100, blocked as above, and labeled with a mouse anti-CDH1 antibody
(BD 610181, BD Biosciences, 1:400 dilution).
Cell Adhesion Assay
Adhesion of TSCs to cell-culture wells was performed using the Vybrant cell
adhesion assay kit (Life Technologies) according to the manufacturer’s in-
structions, with the following details/modifications: 105 cells were plated per
well of a 96-well tissue culture plate, either uncoated or coated with laminin,
and left to attach for 2 hr in serum-free RPMI medium.
RNA/DNA Isolation and Bisulfite Conversion
Genomic DNA and RNA were isolated from the same samples using the
Allprep DNA/RNA Kit (Qiagen). RNA was DNase-treated with the DNA-free
kit (Life Technologies). DNA was bisulfite-converted using the Imprint DNA
Modification Kit (Sigma).
RT-qPCR
For RT-qPCR analysis, total RNA was reverse transcribed by random priming
using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific). qPCR
was performed using Brilliant III Ultra-Fast SYBRGreen qPCRMasterMix (Agi-
lent Technologies) or Mesa Blue qPCR MasterMix Plus (Eurogentec) using
gene-specific primers (see Supplemental Experimental Procedures).
Sequenom MassARRAY
PCR was performed on bisulfite-converted DNA using HotStarTaq DNA Poly-
merase (Qiagen) and target-specific primers (see Supplemental Experimental
Procedures); samples were processed using the ‘‘T’’ Cleavage MassCLEAVE
Reagent Kit (Agena Bioscience) and subjected to MALDI-TOF analysis using
the MassARRAY system, according to the manufacturer’s instructions.
RNA-Seq Library Generation and Sequencing
mRNA was purified from 45–400 ng of total RNA using a Dynabeads mRNA
Purification Kit (Life Technologies). For each genotype, three strand-specific
libraries were generated from single EPCs using the ScriptSeq v2 RNA-Seq
Library Preparation Kit (Epicentre), according to the manufacturer’s instruc-
tions. Indexed libraries were pooled and sequenced on an Illumina HiSeq
2000 or 2500 platform using 50 bp (Dnmt3 libraries) or 100 bp (Ascl2 libraries)
single-end reads. Reads were trimmed using ‘‘Trim Galore!’’ and mapped to
the NCBIM37 genome assembly using TopHat (Trapnell et al., 2009).
BS-Seq Library Generation and Sequencing
Whole-genome BS-seq libraries were prepared from 25–70 ng of genomic
DNA, using a post-bisulfite adaptor tagging protocol, as previously described
(Peat et al., 2014). In brief, first-strand synthesis was performed on bisulfite-
converted DNA using biotin-tagged random primers containing part of the Illu-
mina-compatible 50 adaptor sequence. After biotin capture using Dynabeads
(Life Technologies), second-strand synthesis was performed using random
primers containing part of the Illumina-compatible 30 adaptor sequence.
DNA was then eluted from the beads and libraries amplified using Phusion
(New England Biolabs). Libraries were sequenced on an Illumina HiSeq 2500
platform using 100-bp paired-end reads. Reads were trimmed using ‘‘Trim
Galore!’’ and mapped to the NCBIM37 genome assembly using bismark
(Krueger and Andrews, 2011).
Bioinformatics Analyses
All data analyses were performed using Seqmonk and/or R scripts. Differential
gene expression analysis was performed with DEseq (Anders and Huber,
2010), using a 1% false discovery rate cut-off and minimum fold change
of 2. GO analysis was performed using topGO. To measure DNA methylation
at given genomic features, methylation calls from both strands at CpG sites
were pooled; regions that had at least three CpGs covered by at least five
reads were selected and the average CpGmethylation value per region calcu-
lated. Promoters were defined as 1 kb to +500 bp relative to each TSS; CGIental Cell 36, 152–163, January 25, 2016 ª2016 The Authors 161
annotation was from Illingworth et al. (2008). For DMR detection, methylation
calls from running windows containing five CpGs within 1 kb were pooled; sig-
nificant differences were determined using a Fisher test and a Benjamini-
Hochberg corrected p value cut-off of 0.01. Significantly different windows
within 200 bp were merged into DMRs, and only DMRs with a methylation dif-
ference larger than 20% were kept. LiftOver was used to identify regions of
synteny to the identified DMRs in human. Of 4,084 syntenic regions identified,
353 were covered by at least five reads in human oocyte and morula reduced
representation bisulfite sequencing data (Guo et al., 2014) and used for further
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